Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.
BACKGROUND
In vivo CD8+ cell depletions in pathogenic SIV infections identified a key role for cellular immunity in controlling viral load (VL) and disease progression. However, similar studies gave discordant results in chronically-infected SMs, leading some authors to propose that in natural hosts, SIV replication is independent of cellular immunity. To assess the role of cellular immune responses in the control of SIV replication in natural hosts, we investigated the impact of CD8+ cell depletion during acute SIV infection in AGMs.


RESULTS
Nine AGMs were infected with SIVagm.sab and were followed up to day 225 p.i. Four were intravenously infused with the cM-T807 antibody on days 0 (50 mg/kg), 6, and 13 (10 mg/kg, respectively) post infection (p.i.). CD8+ cells were depleted for up to 28 days p.i. in peripheral blood and LNs in all treated AGMs. Partial CD8+ T cell depletion occurred in the intestine. SIVagm VLs peaked at similar levels in both groups (107-108 RNA copies/ml). However, while VLs were controlled in undepleted AGMs, reaching set-point levels (104-105 RNA copies/ml) by day 28 p.i., high VLs (>106 RNA copies/ml) were maintained by day 21 p.i. in CD8-depleted AGMs. By day 42 p.i., VLs were comparable between the two groups. The levels of immune activation and proliferation remained elevated up to day 72 p.i. in CD8-depleted AGMs and returned to preinfection levels in controls by day 28 p.i. None of the CD8-depleted animals progressed to AIDS.


CONCLUSIONS
CD8+ cells are responsible for a partial control of postacute viral replication in SIVagm.sab-infected AGMs. In contrast to macaques, the SIVagm-infected AGMs are able to control viral replication after recovery of the CD8+ T cells and avoid disease progression.
Gaufin
Thaidra
T
Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA.
Ribeiro
Ruy M
RM
Gautam
Rajeev
R
Dufour
Jason
J
Mandell
Daniel
D
Apetrei
Cristian
C
Pandrea
Ivona
I
D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002522:Chlorocebus aethiops; D005500:Follow-Up Studies; D008212:Lymphocyte Depletion; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000821:virology*; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D019562:Viral Load; D014779:Virus Replication
Immunology. 2008 Jun;124(2):215-22
18201184
J Virol. 2005 May;79(10):6249-59
15858009
Blood. 2009 Apr 30;113(18):4250-61
19168789
J Virol. 2008 Nov;82(22):11181-96
18787003
J Exp Med. 1999 Mar 15;189(6):991-8
10075982
Virology. 2003 Dec 5;317(1):119-27
14675630
J Virol. 1995 Sep;69(9):5838-42
7637030
PLoS Pathog. 2009 Dec;5(12):e1000691
20011508
J Virol. 2007 Apr;81(7):3465-76
17251286
J Virol. 2008 Dec;82(23):11577-88
18829748
J Virol. 2008 Jul;82(13):6758-61
18434394
J Virol. 2007 Aug;81(15):7913-23
17507488
Virology. 2006 Sep 15;353(1):83-98
16814356
J Exp Med. 1995 Apr 1;181(4):1365-72
7699324
J Virol. 2006 May;80(10):4858-67
16641277
Blood. 2006 Jul 1;108(1):209-17
16522814
J Virol. 1998 Jan;72(1):164-9
9420212
J Virol. 2004 May;78(10):5324-37
15113912
Am J Pathol. 1999 Jun;154(6):1923-32
10362819
Blood. 2010 Apr 15;115(15):3070-8
20147699
J Virol. 2003 Jan;77(2):1163-74
12502833
J Immunol. 2007 Jun 15;178(12):8002-12
17548637
J Virol. 2008 Jun;82(11):5618-30
18367534
Virology. 2005 Dec 20;343(2):246-55
16185742
Clin Microbiol Rev. 2006 Oct;19(4):728-62
17041142
J Virol. 2009 Mar;83(6):2770-7
19109377
J Virol. 2009 Aug;83(16):7894-908
19493994
J Virol. 2008 Apr;82(7):3713-24
18216122
Science. 1999 Feb 5;283(5403):857-60
9933172
AIDS Res Hum Retroviruses. 2001 Jul 1;17(10):937-52
11461679
J Virol. 2008 Oct;82(19):9629-38
18667509
J Gen Virol. 2005 Dec;86(Pt 12):3375-3384
16298985
J Virol. 2009 Jan;83(2):572-83
18987149
AIDS. 2001 Dec 7;15(18):2461-2
11826852
J Exp Med. 2000 Jun 5;191(11):1921-31
10839807
J Virol. 2009 Oct;83(20):10347-57
19656874
J Virol. 2002 Oct;76(20):10256-63
12239301
J Virol. 2000 Feb;74(3):1209-23
10627531
J Exp Med. 2009 Jul 6;206(7):1575-88
19546246
Trends Immunol. 2008 Sep;29(9):419-28
18676179
J Immunol. 1999 May 1;162(9):5127-33
10227983
J Virol. 2007 Aug;81(16):8827-32
17537848
J Virol. 2006 Apr;80(7):3301-9
16537597
J Virol. 2001 Nov;75(21):10187-99
11581387
J Immunol. 2007 Sep 1;179(5):3035-46
17709518
J Virol. 2003 May;77(10):5749-58
12719568
Blood. 2006 Jun 15;107(12):4781-9
16467198
J Virol. 2006 Mar;80(6):2771-83
16501086
AIDS. 2002 Apr 12;16(6):829-38
11919484
J Virol. 2008 Jun;82(11):5501-9
18385229
J Virol. 2000 Feb;74(4):1648-57
10644334
J Immunol. 2008 Nov 15;181(10):6687-91
18981083
J Virol. 2006 May;80(10):5074-7
16641299
Blood. 2007 Feb 1;109(3):1069-76
17003371
J Immunol. 2000 Jan 15;164(2):934-43
10623842
J Virol. 2005 Apr;79(7):4043-54
15767406
J Med Primatol. 2006 Aug;35(4-5):194-201
16872282
J Clin Invest. 1998 Jul 1;102(1):223-31
9649576
Eur J Immunol. 2001 Nov;31(11):3207-17
11745337